The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comprehensive molecular characterization of colorectal cancer reveals genomic predictors of immune cell infiltrates.
 
Marios Giannakis
No Relationships to Disclose
 
Sachet Shukla
No Relationships to Disclose
 
Jasmine Xinmeng Mu
No Relationships to Disclose
 
Reiko Nishihara
No Relationships to Disclose
 
Mai Yamauchi
No Relationships to Disclose
 
Yasutaka Sukawa
No Relationships to Disclose
 
Zhi Rong Qian
No Relationships to Disclose
 
Katsuhiko Nosho
No Relationships to Disclose
 
Kentaro Inamura
No Relationships to Disclose
 
Samira Bahl
No Relationships to Disclose
 
Kimmie Ng
Consulting or Advisory Role - CBPartners; Genentech/Roche; Havas Life Metro; McCann Regan Campbell Ward
Research Funding - Genentech/Roche (Inst); Pharmavite (Inst)
Travel, Accommodations, Expenses - Gilead Sciences
 
Andrew T. Chan
Consulting or Advisory Role - Bayer; Pfizer
 
Jeffrey A. Meyerhardt
Research Funding - Biothera (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst)
 
Stacey B. Gabriel
No Relationships to Disclose
 
Eric Lander
No Relationships to Disclose
 
Catherine Wu
No Relationships to Disclose
 
Gad Getz
No Relationships to Disclose
 
Charles S. Fuchs
Consulting or Advisory Role - Acceleron Pharma; Amgen; Bayer; Bristol-Myers Squibb; Celgene; Genentech; Gilead Sciences; Lilly; MedImmune; Merck; Pfizer; Roche Pharma AG; Sanofi; Takeda; Vertex
 
Shuji Ogino
No Relationships to Disclose
 
Levi A. Garraway
Consulting or Advisory Role - Boehringer Ingelheim; Foundation Medicine; Millennium; Novartis; Takeda
Research Funding - Novartis